Adapted Behavioural Activation for Bipolar Depression: A Randomised Multiple Baseline Case Series.
Kim WrightMohammod MostazirElla BaileyBarnaby D DunnHeather O'MahenMichaela SibseyZoe ThomasPublished in: Brain sciences (2022)
Behavioural Activation (BA) is associated with a substantial evidence base for treatment of acute unipolar depression, and has promise as an easily disseminable psychological intervention for bipolar depression. Using a randomised multiple baseline case series design we examined the feasibility and acceptability of an adapted version of BA in a U.K. outpatient sample of 12 adults with acute bipolar depression. Participants were allocated at random to a 3-8 week wait period before being offered up to 20 sessions of BA. They completed outcome measures at intake, pre- and post-treatment and weekly symptom measures across the study period. Retention in therapy was high (11/12 participants completed the target minimum number of sessions), and all participants returning acceptability measures reported high levels of satisfaction with the intervention. No therapy-related serious adverse events were reported, nor were there exacerbations in manic symptoms that were judged to be a result of the intervention. The pattern of change on outcome measures is consistent with the potential for clinical benefit; six of the nine participants with a stable baseline showed clinically significant improvement on the primary outcome measure. The findings suggest adapted BA for bipolar depression is a feasible and acceptable approach that merits further investigation.
Keyphrases
- risk assessment
- sleep quality
- depressive symptoms
- bipolar disorder
- randomized controlled trial
- clinical trial
- liver failure
- chronic obstructive pulmonary disease
- study protocol
- open label
- cystic fibrosis
- drug induced
- double blind
- machine learning
- hepatitis b virus
- climate change
- weight gain
- acute respiratory distress syndrome
- mechanical ventilation